Australasia
Australia's BGH sets $2.5b hard cap for Fund II
BGH Capital has set the hard cap for its second Australia and New Zealand-focused fund at approximately AUD 3.5bn (USD 2.5bn), having reached a first close of AUD 3bn.
CapVest tops BGH's bid for Australia's Virtus Health
CapVest Partners, a UK-headquartered private equity firm that primarily invests in Europe and North America, has entered the race for Australian fertility care business Virtus Health with an AUD 650.1m (USD 469m) offer.
TPG-owned clinical trials player raises new equity, debt
Novotech, an Asia-based clinical trials specialist controlled by TPG Capital, has secured USD 760m in new equity and debt financing at a post-deal valuation of approximately USD 3bn.
Quadrant exits Australia experiential tourism business
Quadrant Private Equity has sold Journey Beyond, an Australia-based experiential tourism business, to US-based Hornblower Group, which is best known for offering cruise and sightseeing packages.
Asia PE investment hits new high in 2021
A rebound in China-based activity took Asia private equity investment to a record USD 105.3bn in the fourth quarter, ensuring that 2021 represents a new high watermark for the industry.
Australia's Allegro names Fay Bou as third partner
Australia turnaround investor Allegro Funds has appointed Fay Bou as its third partner, serving alongside co-founders Adrian Loader and Chester Moynihan.
New Zealand's AskNicely raises $32m Series B
Five Elms Capital, a specialist growth investor in software start-ups globally, has led a USD 32m Series B round for New Zealand and US-based customer feedback platform AskNicely.
PE consortium backs New Zealand fertility business
Pioneer Capital, New Zealand Superannuation Fund, and Comprador Holdings have together acquired a 70% stake in Fertility Associates, a New Zealand-based fertility treatment provider.
Australia's PEP secures fourth exit in a fortnight
Pacific Equity Partners (PEP) has agreed on exits from two energy infrastructure-related businesses, taking the Australia-based private equity firm to four announced liquidity events within a fortnight.
Blackbird backs Australia 3D cell culture platform
Australia’s Blackbird Ventures has led a $25 million Series B round for Inventia Life Science, a local start-up that provides 3D cell cultures for research and clinical purposes.
Australia's Rokt raises $325m Series E at $1.9b valuation
Tiger Global Management has led a $325 million Series E round for Australia-based e-commerce marketing technology provider Rokt.
BGH makes $432m bid for Australia's Virtus Health
BGH Capital has submitted a take-private bid for Virtus Health, an Australia-based fertility care services provider, that values the business at approximately A$607.3 million ($432 million).
2022 preview: SaaS
Software-as-a-service continues to benefit from a digitalization push across multiple markets. Investors are looking for differentiation in a market characterized by high valuations and intense competition
2021 in review: Boom time
Cheap debt and a desire for assets that deliver technology-driven growth have propelled Asia private equity investment to new highs and supported a resurgence in exits. But fundraising still fails to convince
PEP sells Australia, New Zealand healthcare businesses
Pacific Equity Partners (PEP) has agreed two healthcare exits, with Australia-based medical devices distributor LifeHealthcare to be sold to Ebos Group and New Zealand corporate hospital platform Evolution Healthcare going to QIC and Sunsuper.
OTPP joins KKR as investor in Australia's GreenCollar
Ontario Teachers’ Pension Plan (OTPP) has made an investment of undisclosed size in KKR-backed GreenCollar, an environmental services provider that helped establish Australia’s carbon credit market.
Australia fintech player Finder raises $21m
Finder, an Australian financial technology start-up with a diversified suite of retail investor services, has raised A$30 million ($21.5 million) from local VC firm Future Now Capital.
Singapore's Aura acquires Australia vaccination player
Singapore-based Aura Private Equity has acquired a majority stake in Australian Vaccine Services (AVS), a leading provider of corporate flu vaccinations.
Asia exits: Pass the parcel
Sponsor-to-sponsor exits are set to reach a record high in Asia this year as private equity firms increase velocity of deployment and some strategics remain in a pandemic-induced funk
Goldman invests $96m in Australia disability housing player
Goldman Sachs Asset Management has committed A$137 million ($96 million) to Synergis, an Australian investment platform focused on providing housing for people with disabilities.
Blue Sky spinout backs Australia cosmetic medical business
Fortitude Investment Partners, an Australia-based private equity firm established by professionals from Blue Sky Alternative Investments, has backed cosmetic medical business Aura Medical Group.
Horizons leads Series B for Australia healthcare AI start-up
Horizons Ventures, the private investment arm of Hong Kong billionaire Li Ka-Shing, has led a A$129 million ($92.3 million) Series B round for Australia’s Harrison.ai, a clinical artificial intelligence (AI) developer.
Airbus backs Australia quantum computing player
Airbus Ventures has led a $25 million Series B round for Australia’s Q-Ctrl, a quantum computing developer increasingly geared toward space tech and orbital infrastructure.
Australia food-ordering start-up raises $63m
Tiger Global Management has led an A$89 million ($63.4 million) Series A round for Australian food-ordering start-up Mr Yum. In the past 12 months, 44% of Australians have used the platform.